#ITI#Administration of Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and Avian Beta Defensin as Adjuvants in Inactivated Inclusion Body Hepatitis Virus and its Hexon Protein-Based Experimental Vaccine Formulations in Chickens#FTI#
#IRE#Inclusion body hepatitis (IBH) is one of the major infectious diseases adversely affecting the poultry industry of the United States and Canada. Currently, no effective and safe vaccine is available for the control of IBH virus (IBHV) infection in chickens. However, based on the excellent safety and immunogenic profiles of experimental veterinary vaccines developed with the use of new generation adjuvants, we hypothesized that characterization of vaccine formulations containing inactivated IBHV or its capsid protein hexon as antigens, along with poly[b;di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) and avian beta defensin 2 (ABD2) as vaccine adjuvants, will be helpful in development of an effective and safe vaccine formulation for IBH. Our data demonstrated that experimental administration of vaccine formulations containing inactivated IBHV and a mixture of PCEP with or without ABD2 as an adjuvant induced significantly higher antibody responses compared with other vaccine formulations, while hexon protein-based vaccine formulations showed relatively lower levels of antibody responses. Thus, a vaccine formulation containing inactivated IBHV with PCEP or a mixture of PCEP and ABD2 (with a reduced dosage of PCEP) as an adjuvant may serve as a potential vaccine candidate. However, in order to overcome the risks associated with whole virus inactivated vaccines, characterization of additional viral capsid proteins, including fiber protein and penton of IBHV along with hexon protein in combination with more new generation adjuvants, will be helpful in further improvements of vaccines against IBHV infection. Â© 2015 American Association of Avian Pathologists.#FRE#
#IPC#adjuvant; avian beta defensin; chicken; hexon protein; inclusion body hepatitis; polyphosphazene; vaccine#FPC#
#IRF#Ahmad M.D., Zaman S., Mushtaq M.H., Anjum A.A., Akram M., Comparative pathogenicity of liver homogenate and cell culture propagated hydropericardium syndrome virus in broiler birds, Pak. Vet. J., 31, pp. 321-326, (2011); 
Alexander H.S., Huber P., Cao J., Krell P.J., Nagy E., Growth characteristics of fowl adenovirus type 8 in a chicken hepatoma cell line, J. Virol. Methods, 74, pp. 9-14, (1998); 
Alvarado I.R., Villegas P., El-Attrache J., Jensen E., Rosales G., Perozo F., Purvis L.B., Genetic characterization, pathogenicity, and protection studies with an avian adenovirus isolate associated with inclusion body hepatitis, Avian Dis., 51, pp. 27-32, (2007); 
Andrianov A.K., Decollibus D.P., Marin A., Webb A., Griffin Y., Webby R.J., PCPP-formulated H5N1 influenza vaccine displays improved stability and dose-sparing effect in lethal challenge studies, J. Pharm. Sci., 100, pp. 1436-1443, (2011); 
Andrianov A.K., Marin A., Chen J., Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phospha-zene], Biomacromolecules, 7, pp. 394-399, (2006); 
Asthana M., Chandra R., Kumar R., Hydropericardium syndrome: Current state and future developments, Arch. Virol., 158, pp. 921-931, (2013); 
Awate S., Wilson H.L., Singh B., Babiuk L.A., Mutwiri G., The adjuvant PCEP induces recruitment of myeloid and lymphoid cells at the injection site and draining lymph node, Vaccine, 32, pp. 2420-2427, (2014); 
Bradley R.R., Lynch D.M., Iampietro M.J., Borducchi E.N., Barouch D.H., Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection, J. Virol., 86, pp. 625-629, (2012); 
Bradley R.R., Maxfield L.F., Lynch D.M., Iampietro M.J., Borducchi E.N., Barouch D.H., Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions, J. Virol., 86, pp. 1267-1272, (2012); 
Chakrabarti S., Mautner V., Osman H., Collingham K.E., Fegan C.D., Klapper P.E., Moss P.A., Milligan D.W., Adenovirus infections following allogeneic stem cell transplantation: Incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery, Blood, 100, pp. 1619-1627, (2002); 
Cheng C., Gall J.G., Nason M., King C.R., Koup R.A., Roederer M., McElrath M.J., Morgan C.A., Churchyard G., Baden L.R., Duerr A.C., Keefer M.C., Graham B.S., Nabel G.J., Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization, J. Virol., 84, pp. 630-638, (2010); 
Dar A., Gomis S., Shirley I., Mutwiri G., Brownlie R., Potter A., Gerdts V., Tikoo S.K., Pathotypic and molecular characterization of a fowl adenovirus associated with inclusion body hepatitis in Saskatchewan chickens, Avian Dis., 56, pp. 73-81, (2012); 
Dar A., Lai K., Dent D., Potter A., Gerdts V., Babiuk L.A., Mutwiri G.K., Administration of poly[di(sodium carboxylatoethylphenoxy)]-phosphazene (PCEP) as adjuvant activated mixed Th1/Th2 immune responses in pigs, Vet. Immunol. Immunopathol., 146, pp. 289-295, (2012); 
Davison S., Gingerich E.N., Casavant S., Eckroade R.J., Evaluation of the efficacy of a live fowlpox-vectored infectious laryngo-tracheitis/avian encephalomyelitis vaccine against ILT viral challenge, Avian Dis., 50, pp. 50-54, (2006); 
Eng N.F., Garlapati S., Gerdts V., Babiuk L.A., Mutwiri G.K., PCEP enhances IgA mucosal immune responses in mice following different immunization routes with influenza virus antigens, J. Immune Based Ther. Vaccines, 8, (2010); 
Eregae M.E., Dewey C.E., McEwen S.A., Ouckama R., Ojkic D., Guerin M.T., Flock prevalence of exposure to avian adeno-associated virus, chicken anemia virus, fowl adenovirus, and infectious bursal disease virus among Ontario broiler chicken flocks, Avian Dis., 58, pp. 71-77, (2014); 
Feuchtinger T., Richard C., Pfeiffer M., Neuhauser F., Lucke J., Handgretinger R., Greil J., Bader P., Klingebiel T., Schlegel P.G., Jahn G., Niethammer D., Lang P., Adenoviral infections after transplantation of positive selected stem cells from haploidentical donors in children: An update, Klin. Padiatr., 217, pp. 339-344, (2005); 
Furuya Y., Return of inactivated whole-virus vaccine for superior efficacy, Immunol. Cell Biol., 90, pp. 571-578, (2012); 
Gahery-Segard H., Farace F., Godfrin D., Gaston J., Lengagne R., Tursz T., Boulanger P., Guillet J.G., Immune response to recombinant capsid proteins of adenovirus in humans: Antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity, J. Virol., 72, pp. 2388-2397, (1998); 
Garlapati S., Eng N.F., Kiros T.G., Kindrachuk J., Mutwiri G.K., Hancock R.E., Halperin S.A., Potter A.A., Babiuk L.A., Gerdts V., Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis, Vaccine, 29, pp. 6540-6548, (2011); 
Geeraedts F., Bungener L., Pool J., Ter Veer W., Wilschut J., Huckriede A., Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs, Influenza Other Respir. Viruses, 2, pp. 41-51, (2008); 
Geeraedts F., Goutagny N., Hornung V., Severa M., De Haan A., Pool J., Wilschut J., Fitzgerald K.A., Huckriede A., Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by toll-like receptor signalling, PLoS Pathog., 4, (2008); 
Gomis S., Goodhope A.R., Ojkic A.D., Willson P., Inclusion body hepatitis as a primary disease in broilers in Saskatchewan Canada, Avian Dis., 50, pp. 550-555, (2006); 
Gracia A., Polewicz M., Halperin S.A., Hancock R.E., Potter A.A., Babiuk L.A., Gerdts V., Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations, Vaccine, 29, pp. 1595-1604, (2011); 
Gupta S.K., Deb R., Dey S., Chellappa M.M., Toll-like receptor-based adjuvants: Enhancing the immune response to vaccines against infectious diseases of chicken, Expert Rev. Vaccines, 13, pp. 909-925, (2014); 
Haase A.T., Mautner V., Pereira H.G., The immunogenicity of adenovirus type 5 structural proteins, J. Immunol., 108, pp. 483-485, (1972); 
Hong S.S., Habib N.A., Franqueville L., Jensen S., Boulanger P.A., Identification of adenovirus (Ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (Addl1520) for treatment of liver tumors, J. Virol., 77, pp. 10366-10375, (2003); 
Hong S.S., Szolajska E., Schoehn G., Franqueville L., Myhre S., Lindholm L., Ruigrok R.W., Boulanger P., Chroboczek J., The 100K-chaperone protein from adenovirus serotype 2 (subgroup C) assists in trimerization and nuclear localization of hexons from subgroups C and B adenoviruses, J. Mol. Biol., 352, pp. 125-138, (2005); 
Hovden A.O., Cox R.J., Haaheim L.R., Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice, Scand. J. Immunol., 62, pp. 36-44, (2005); 
Kim M.S., Lim T.H., Lee D.H., Youn H.N., Yuk S.S., Kim B.Y., Choi S.W., Jung C.H., Han J.H., Song C.S., An inactivated oil-emulsion fowl adenovirus serotype 4 vaccine provides broad cross-protection against various serotypes of fowl adenovirus, Vaccine, 32, pp. 3564-3568, (2014); 
Kjaerup R.M., Dalgaard T.S., Norup L.R., Bergman I.M., Sorensen P., Juul-Madsen H.R., Adjuvant effects of mannose-binding lectin ligands on the immune response to infectious bronchitis vaccine in chickens with high or low serum mannose-binding lectin concentrations, Immunobiology, 219, pp. 263-274, (2014); 
Kumar R., Chandra R., Shukla S.K., Agrawal D.K., Kumar M., Hydropericardium syndrome (HPS) in India: A preliminary study on the causative agent and control of the disease by inactivated autogenous vaccine, Trop. Anim. Health Prod., 29, pp. 158-164, (1997); 
Linde A., Ross C.R., Davis E.G., Dib L., Blecha F., Melgarejo T., Innate immunity and host defense peptides in veterinary medicine, J. Vet. Intern. Med., 22, pp. 247-265, (2008); 
Lobanova L.M., Eng N.F., Satkunarajah M., Mutwiri G.K., Rini J.M., Zakhartchouk A.N., The recombinant globular head domain of the measles virus hemagglutinin protein as a subunit vaccine against measles, Vaccine, 30, pp. 3061-3067, (2012); 
Ma X.T., Xu B., An L.L., Dong C.Y., Lin Y.M., Shi Y., Wu K.F., Vaccine with beta-defensin 2-transduced leukemic cells activates innate and adaptive immunity to elicit potent antileukemia responses, Cancer Res., 66, pp. 1169-1176, (2006); 
Mansoor M.K., Hussain I., Arshad M., Muhammad G., Preparation and evaluation of chicken embryo-adapted fowl adenovirus serotype 4 vaccine in broiler chickens, Trop. Anim. Health Prod., 43, pp. 331-338, (2011); 
Mapletoft J.W., Latimer L., Babiuk L.A., Van Drunen Littel-Van Den Hurk S., Intranasal immunization of mice with a bovine respiratory syncytial virus vaccine induces superior immunity and protection compared to those by subcutaneous delivery or combinations of intranasal and subcutaneous prime-boost strategies, Clin. Vaccine Immunol., 17, pp. 23-35, (2010); 
Mapletoft J.W., Oumouna M., Kovacs-Nolan J., Latimer L., Mutwiri G., Babiuk L.A., Hurk Den Littel-Van Drunen S.Van, Intranasal immunization of mice with a formalin-inactivated bovine respiratory syncytial virus vaccine co-formulated with CpG oligodeoxynucleotides and polyphosphazenes results in enhanced protection, J. Gen. Virol., 89, pp. 250-260, (2008); 
Marangon S., Busani L., The use of vaccination in poultry production, Rev. Sci. Tech., 26, pp. 265-274, (2007); 
Marin A., Decollibus D.P., Andrianov A.K., Protein stabilization in aqueous solutions of polyphosphazene polyelectrolyte and non-ionic surfactants, Biomacromolecules, 11, pp. 2268-2273, (2010); 
Mautner V., Willcox H.N., Adenovirus antigens: A model system in mice for subunit vaccination, J. Gen. Virol., 25, pp. 325-336, (1974); 
McConnell M.J., Danthinne X., Imperiale M.J., Characterization of a permissive epitope insertion site in adenovirus hexon, J. Virol., 80, pp. 5361-5370, (2006); 
Mei H.F., Jin X.B., Zhu J.Y., Zeng A.H., Wu Q., Lu X.M., Li X.B., Shen J., Beta-defensin 2 as an adjuvant promotes anti-melanoma immune responses and inhibits the growth of implanted murine melanoma in vivo, PLoS One, 7, (2012); 
Molinier-Frenkel V., Gahery-Segard H., Mehtali M., Le Boulaire C., Ribault S., Boulanger P., Tursz T., Guillet J.G., Farace F., Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes, J. Virol., 74, pp. 7678-7682, (2000); 
Molinier-Frenkel V., Lengagne R., Gaden F., Hong S.S., Choppin J., Gahery-Segard H., Boulanger P., Guillet J.G., Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response, J. Virol., 76, pp. 127-135, (2002); 
Mutinelli F., Aufiero G.M., Pozzato N., Marangon S., Agrimi U., Vaccari G., Vincenzi G., Eradication of scrapie in a Massese sheep flock by PrP allele selection, Vet. Rec., 152, (2003); 
Mutwiri G., Benjamin P., Soita H., Babiuk L.A., Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with hepatitis B virus surface antigen, Vaccine, 26, pp. 2680-2688, (2008); 
Mutwiri G., Benjamin P., Soita H., Townsend H., Yost R., Roberts B., Andrianov A.K., Babiuk L.A., Poly[di(sodium carboxyla-toethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens, Vaccine, 25, pp. 1204-1213, (2007); 
Mutwiri G., Gerdts V., Lopez M., Babiuk L.A., Innate immunity and new adjuvants, Rev. Sci. Tech., 26, pp. 147-156, (2007); 
Onion D., Crompton L.J., Milligan D.W., Moss P.A., Lee S.P., Mautner V., The CD4+ T-cell response to adenovirus is focused against conserved residues within the hexon protein, J. Gen. Virol., 88, pp. 2417-2425, (2007); 
Pasternak J.A., Ng S.H., Wilson H.L., A single, low dose oral antigen exposure in newborn piglets primes mucosal immunity if administered with CpG oligodeoxynucleotides and polyphosphazene adjuvants, Vet. Immunol. Immunopathol., 161, pp. 211-221, (2014); 
Pereira C.G., Marin S.Y., Santos B.M., Resende J.S., Resende M., Gomes A.M., Martins N.R.S., Occurrence of aviadenovirus in chickens from the poultry industry of Minas Gerais, Arq. Bras. Med. Vet. Zootec., 66, pp. 801-808, (2014); 
Roh H.J., Hilt D.A., Williams S.M., Jackwood M.W., Evaluation of infectious bronchitis virus Arkansas-type vaccine failure in commercial broilers, Avian Dis., 57, pp. 248-259, (2013); 
Schachner A., Marek A., Jaskulska B., Bilic I., Hess M., Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS), Vaccine, 32, pp. 1086-1092, (2014); 
Schonewille E., Jaspers R., Paul G., Hess M., Specific-pathogen-free chickens vaccinated with a live FAdV-4 vaccine are fully protected against a severe challenge even in the absence of neutralizing antibodies, Avian Dis., 54, pp. 905-910, (2010); 
Senties-Cue C.G., Wills R.W., Stayer P.A., Burleson M.A., Magee D.L., Epidemiology and effect on production parameters of an outbreak of inclusion body hepatitis in broilers, Avian Dis., 54, pp. 74-78, (2010); 
Shah M.S., Ashraf A., Rahman M., Khan M.I., Qureshi J.A., A subunit vaccine against hydropericardium syndrome using adenovirus penton capsid protein, Vaccine, 30, pp. 7153-7156, (2012); 
Sumida S.M., Truitt D.M., Kishko M.G., Arthur J.C., Jackson S.S., Gorgone D.A., Lifton M.A., Koudstaal W., Pau M.G., Kostense S., Havenga M.J., Goudsmit J., Letvin N.L., Barouch D.H., Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors, J. Virol., 78, pp. 2666-2673, (2004); 
Sumida S.M., Truitt D.M., Lemckert A.A., Vogels R., Custers J.H., Addo M.M., Lockman S., Peter T., Peyerl F.W., Kishko M.G., Jackson S.S., Gorgone D.A., Lifton M.A., Essex M., Walker B.D., Goudsmit J., Havenga M.J., Barouch D.H., Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein, J. Immunol., 174, pp. 7179-7185, (2005); 
Tang Y., Lu J., Wu P., Liu Z., Tian Z., Zha G., Chen H., Wang Q., Wang Q., Hou F., Kang S.M., Hou J., Inactivated vaccine with adjuvants consisting of pattern recognition receptor agonists confers protection against avian influenza viruses in chickens, Vet. Microbiol., 172, pp. 120-128, (2014); 
Toogood C.I., Crompton J., Hay R.T., Antipeptide antisera define neutralizing epitopes on the adenovirus hexon, J. Gen. Virol., 73, pp. 1429-1435, (1992); 
Youil R., Toner T.J., Su Q., Chen M., Tang A., Bett A.J., Casimiro D., Hexon gene switch strategy for the generation of chimeric recombinant adenovirus, Hum. Gene Ther., 13, pp. 311-320, (2002); 
Zhang H.H., Yang X.M., Xie Q.M., Ma J.Y., Luo Y.N., Cao Y.C., Chen F., Bi Y.Z., The potent adjuvant effects of chicken beta-defensin-1 when genetically fused with infectious bursal disease virus VP2 gene, Vet. Immunol. Immunopathol., 136, pp. 92-97, (2010)#FRF#
